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X-ray diffractionAbstract A serie of N-acetyl phenothiazines and related compounds was synthesized by means of
the acetylation reaction of the corresponding phenothiazine with the appropriate reagent using
microwave irradiation. Structural elucidation of these heterocyclic derivatives was done using 1H,
13C NMR spectra. The equilibra between conformationals enantiomers were studied as a possible
atropisomerism case. The single crystal X-ray diffraction of some derivatives was also recorded and
the presence of enantiomers could be confirmed. The antifungal activity evaluation of all N-acetyl
phenothiazines prepared by us in this and in a previous work, was performed in vitro against 163
isolated human pathogenic yeasts and filamentous fungi, including: Cryptococcus neoformans, Can-
dida albicans, Candida non-albicans, Aspergillus and Acremonium-Fusarium. The most promising
compounds were those bearing one chlorine or bromine atom attached to the N-acetyl group. Theseersidad
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for antifungal activityN-haloacetyl phenothicompounds were as active as 5-fluorocitosine (5-FC) or fluconazole (FCZ), currently in clinical use.
A structure-activity relationship (SAR) and a quantitative structure-activity relationship (QSAR)
for antifungal activity of each genus were established.
 2017 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, the incidence and severity of fungal diseases
has increased, particularly in population with a broad list of
inmunocompromised medical conditions, such as cancer,
AIDS, solid-organ and hematopoietic stem cell transplanta-
tion and in aging population (Casto´n-Osorio et al., 2008;
Shao et al., 2007). Due to the small number of available anti-
fungal agents and infections caused, specially by unusual fun-
gal species, and having into account the different mechanism
of action of them, searching for new and more effective and
less toxic drugs is mandatory (Pfaller, 2012; Kathiravan
et al., 2012). Moreover, the growing of antifungal resistance
to the commercial drugs causes serious problems to the public
health (Shao et al., 2007; Tobudic et al., 2012; Nucci and Marr,
2005).
Phenothiazine, an aromatic tricyclic compound, is the
parent molecule of a multitude of drugs that have enjoyed
varied and extensive use throughout medical and veterinary
practice. These compounds are non-antibiotics with insectici-
dal, antifungal, antibacterial and anthelmintic properties
(Mitchell, 2006; Aaron et al., 2009). Following its extensive
usage over many years, unwanted reactions including neuro-
muscular incoordination, photosensitization and hemolytic
anemia have been reported and these have limited its use
(Pluta et al., 2011).
In the last decade, the antifungal properties of some
antipsychotic phenothiazine derivatives, such as trifluoroper-g. 1 Some phenothiazine deriv
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azines and derivatives –>. Arabian Jourazine, chlorpromazine and fluphenazine, have been described
(Fig. 1) (Afeltra and Verweij, 2003). The active phenothiazine
derivatives had more potent inhibitory activity against fungi,
including phytopathogen filamentous, human pathogen fila-
mentous fungi and yeasts, than against gram-positive and neg-
ative bacteria.
Some years ago our research program has been directed to
synthesis of phenothiazines and their N-acyl derivatives
(Sarmiento et al., 2009; Moltrasio et al., 2006) using conven-
tional and non-conventional methodologies, as microwave
irradiation using a household MW oven, and to investigate
their biological properties. The antifungal activity of several
synthesized phenothiazines, related compound as well as yet
known pharmacological available ones such as pipotiazine
(PIP), a neuroleptic phenothiazine, and promethazine
(PMZ), an antihistaminic phenothiazine (Fig. 1), were
reported by us showing interesting results as antimicotic agents
(Sarmiento et al., 2011). In that opportunity we found that N-
chloroacetyl phenothiazine (1), the simplest of the compounds
tested, showed to be as active as antifungal agents currently
used in clinical (Sarmiento et al., 2011). Due to the important
biological properties of this heterocyclic class, the aim of this
work was to improve the synthesis of N-acyl substituted phe-
nothiazines and related compounds, as well as to synthesize
some others not yet described in the literature, and evaluate
their antifungal activity. Then, with the battery of compounds
available, we attempted to establish the potential structure
activity relationship (SAR and QSAR).atives with antifungal activity.
and derivatives: Preparation, characterization and structure-activity relationship
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N-haloacetyl phenothiazines and derivatives 32. Experimental section
2.1. Chemistry
All the reagents and solvents were analytical or chemical pure
class. 1H NMR and 13C NMR spectra were recorded on Bru-
ker AC 300 or on Bruker Avance 500 or on Varian 200 spec-
trometers. Shifts reported are relative to the signal of the
solvent used in each case, and coupling constants (J) are
reported in Hertz (Hz). Splitting patters are designated as fol-
lows: s: singlet, bs: broad singlet, d: doublet, bd: broad dou-
blet; t: triplet, dd: double doublet, td: triple doublet, q:
quartet, m: multiplet. IR spectra were recorded using a Perkin
Elmer Spectrum One FT-IR spectrophotometer and are
expressed in cm1. High resolution mass spectra were obtained
on Bruker micrOTOF-Q II spectrometer. Microwave-assisted
reactions were carried out into using an Anton Paar Mono-
wave 300 as microwave reactor, heating at 100 C and stirring
at 500 rpm. Melting points were obtained by using a Thomas
Hoover melting point apparatus. Thin layer chromatography
was performed using aluminum plates precoated with Silicagel
60F254 (E-Merck). Spots were visualized in the ultraviolet light
chamber (254 nm). Preparative thin layer chromatography (p-
TLC) was done on Silicagel 60 GF254, Merck. Column chro-
matography was performed by using Silicagel (200–400 mesh,
Merck) with the indicated solvent system. THF was distilled
from sodium/benzophenone.2.2. Preparation of N-acylphenothiazines and phenoxazine 2-7
2.2.1. 10-Chloroacetyl-2-chlorophenothiazine (2)
To a solution of 2-chlorophenothiazine (234 mg, 1 mmol) and
triethylamine (0.2 mL; 1.5 mmol) in ethyl acetate (2 mL) was
added drop by drop chloroacetyl chloride (0.2 mL; 2.4 mmol).
The reaction mixture was irradiated with MW during 15 min
(100 C), then it was allowed to reach room temperature. After
that, it was washed with NaOH 5% (2  3 mL), and finally
with brine. The organic phase was dried with anhydrous Na2-
SO4. Finally the solvent was removed in vacuo. The residue
was purified by p-TLC using n-hexane/dichloromethane (1:1)
as eluent. Compound 2 was obtained as a green solid (280
mg, 90%); m.p. 105–107 C (dichloromethane); m.p. lit.
(Bansode et al., 2009) 115–118 C (diethyl ether). IR (Film):
1694 (CO). 1H NMR (500 MHz, CDCl3): d 4.15 (d,
2J=12.5
Hz, 1H, ACHHCl), 0.25 (d, 2J=12.5 Hz, 1H, ACHHCl),
7.28 (dd, 3J=8.2 Hz, 4J=2.1 Hz, 1H, Ar), 7.33 (td, 3J=7.5
Hz, 4J=1.4 Hz, 1H, Ar), 7.40 (m, 2H, Ar), 7.50 (dd, 3J=7.8
Hz, 4J=1.3 Hz, 1H, Ar), 7.57 (d, 3J=8 Hz, 1H, Ar), 7.67 (d,
4J=2 Hz, 1H, Ar) ppm. 13C NMR (125 MHz, CDCl3): d
41.6 (CH2), 126.3, 127.1, 127.6, 127.7, 127.8, 128.4, 128.6,
133.1, 137.5, 138.9, 165.4 (C‚O) ppm.
2.2.2. 10-Chloroacetyl-2-methylthiophenothiazine (3)
To a solution of 2-methylthiophenothiazine (245 mg, 1 mmol)
and triethylamine (0.2 mL; 1.5 mmol) in ethyl acetate (2 mL)
was added drop by drop chloroacetyl chloride (0.2 mL; 2.4
mmol). The reaction mixture was irradiated with MW during
8 min (100 C), then it was allowed to reach room temperature.
After that, it was washed with NaOH 5% (2  3 mL), and
finally with brine. The organic phase was dried with anhydrousPlease cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
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was purified by p-TLC using n-hexane/dichloromethane (1:1)
as eluent. Compound 3 was obtained as a white solid (270
mg, 85%); m.p. 117–120 C. IR (Film): 1693 (CO). 1H NMR
(500 MHz, CDCl3): d 2.55 (s, 3H, CH3), 4.19 (d,
2J=12.5
Hz, 1H, ACHHCl), 4.22 (d, 2J=12.5 Hz, 1H, ACHHCl),
7.17 (dd, 3J=8.5 Hz, 4J=1.8 Hz, 1H, Ar), 7.29 (td, 3J=7.5
Hz, 4J=1.3 Hz, 1H, Ar), 7.38 (m, 2H, Ar), 7.48 (dd, 3J=7.8
Hz, 4J=1.3 Hz, 1H, Ar), 7.51 (bs, 1H, Ar), 7.59 (d, 3J=8.1
Hz, 1H, Ar) ppm. 13C NMR (125 MHz, CDCl3): d 16.0
(CH3), 41.8 (CH2), 124.2, 125.6, 126.6, 127.4, 127.5, 128.1,
128.2, 137.7, 138.5, 138.7, 165.4 (C‚O) ppm. HRMS (ESI):
calc. for C15H12ClNNaOS2, 343.9941, found 343.9944. Anal.
Calcd for C15H12ClNOS2: C, 55.98; H, 3.76; N, 4.35, S,
19.93. Found: C, 55.95; H, 3.80; N, 4.25, S, 19.80.
2.2.3. 10-Bromoacetylphenothiazine (4) (Diehl and Himbert,
1986)
To a solution of phenothiazine (520 mg, 2.6 mmol) and tri-
ethylamine (0.6 mL; 4 mmol) in ethyl acetate (3 mL) was
added drop by drop bromoacetyl bromide (0.5 mL; 6.2 mmol).
The reaction mixture was irradiated with MW during 6 min
(100 C), then it was allowed to reach room temperature. After
that, it was washed with NaOH 5% (2  3 mL), and finally
with brine. The organic phase was dried with anhydrous Na2-
SO4. Finally the solvent was removed in vacuo. The reaction
mixture obtained was purified p-TLC using n-hexane/dichlor-
omethane (1:3) as eluent. Compound 4 was obtained as a grey
solid (815 mg, 98%); m.p. 113–115 C. IR (Film): 1677 (CO).
1H NMR (300 MHz, CDCl3): d4.00 (s, 2H, CH2), 7.27 (td,
3J=7.6 Hz, 4J=1.4 Hz, 2H, Ar), 7.36 (td, 3J=7.4 Hz,
4J=1.5 Hz, 2H, Ar), 7.47 (dd, 3J=7.6 Hz, 4J=1.5 Hz, 2H,
Ar), 7.62 (dd, 3J=7.6 Hz, 4J=1.2 Hz, 2H, Ar) ppm. 13C
NMR (75 MHz, CDCl3): d 29.7 (CH2), 126.5, 127.3, 127.4,
128.1, 138.0, 165.7 (C‚O) ppm.
2.2.4. 10-dichloroacetylphenothiazine (5) (Kanzawa et al.,
1972)
To a solution of phenothiazine (200 mg, 1 mmol) and triethy-
lamine (0.2 mL; 1.5 mmol) in ethyl acetate (2 mL) was added
drop by drop dichloroacetyl chloride (0.22 mL; 2.3 mmol).
The reaction mixture was irradiated with MW during 20 min
(100 C), then it was allowed to reach room temperature. After
that, it was washed with NaOH 5% (2  3 mL), and finally
with brine. The organic phase was dried with anhydrous Na2-
SO4. Finally the solvent was removed in vacuo. The residue
was purified by p-TLC using n-hexane/dichloromethane (1:2)
as eluent. Compound 5 was obtained as a green solid (190
mg, 60%); m.p. 152–154 C. IR (Film): 1702 (CO).1H NMR
(300 MHz, CDCl3): d6.37 (s, 1H, CH), 7.35 (m, 4H, Ar),
7.50 (d, 3J=7.7 Hz, 2H, Ar), 7.61 (bd, 3J=7.7, 2H, Ar)
ppm. 13C NMR (75 MHz, CDCl3): d 63.7 (CH), 126.5,
127.4, 127.8, 128.3, 137.2, 163.1 (C‚O) ppm.
2.2.5. 10-Trifluoroacetylphenothiazine (6) (Mais et al., 1999;
De Meester and Chu, 1986)
To a solution of phenothiazine (1.00 g, 5 mmol) in ethyl acet-
ate (2 mL) was added drop by drop trifluoroacetic acid (0.8
mL; 13 mmol). The reaction mixture was irradiated with
MW during 5 min. and then it was washed with NaOH 5%
(2  3 mL). The organic phase was dried with anhydrousand derivatives: Preparation, characterization and structure-activity relationship
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was purified by crystallization in ethanol to give 6 as a white
solid (1.00 g, 70%); m.p. 104–105 C. IR (Film): 1698
(CO).1H NMR (300 MHz, CDCl3): d7.30 (td,
3J=7.6 Hz,
4J=1.7 Hz, 2H, Ar), 7.38 (td, 3J=7.8 Hz, 4J=1.7 Hz, 2H,
Ar), 7.47 (dd, 3J=7.5 Hz, 4J=1.8 Hz, 2H, Ar), 7.60 (da,
3J=7.7 Hz, 2H, Ar) ppm. 13C NMR (75 MHz, CDCl3): d
116.2 (q, 1J=288.2 Hz, CF3), 126.5, 127.4, 127.9, 128.2,
133.4, 136.8, 156.0 (q, 2J=37.9 Hz, C‚O) ppm.
2.2.6. 10-Acetylphenoxazine (7) (Ragg at al., 1983)
To a solution of phenoxazine (480 mg, 2.62 mmol) in ethyl
acetate:pyridine (1:1, 3 mL) was added drop by drop acetyl
chloride (0.5 mL; 6.2 mmol). The reaction mixture was irradi-
ated with MW during 15 min, then it was washed with NaOH
5% (2  3 mL) and the organic phase was dried with anhy-
drous Na2SO4. Finally the solvent was removed in vacuo.
The reaction mixture obtained was purified p-TLC using n-
hexane/dichloromethane (1:4) as eluent. Compound 7 was
obtained as a green solid (526 mg, 90%); m.p. 138–140 C.
IR (KBr): 1668 (CO). 1H NMR (200 MHz, CDCl3): d2.35 (s,
3H, CH3), 7.05–7.25 (m, 6H, Ar), 7.50 (m, 2H, Ar) ppm.
13C
NMR (50 MHz, CDCl3): d 23.3 (CH3), 117.1, 123.6, 125.4,
127.1, 129.7, 151.3, 169.3 (C‚O) ppm.
2.3. Crystallographic data of compounds 1, 3, 9 and 18
Data for suitable single crystals were collected at room temper-
ature, using a Gemini A diffractometer, Oxford Diffraction,
Eos CCD detector with graphite-mono chromate Mo Ka (k
= 0.71073 A˚) radiation. Data-collection strategy (x-scan)
and data reduction (integrated and scaled intensities) followed
standard procedures implemented in the CrystAlisProsuite of
programs (CrysAlisPro, 2012). Data were corrected empiri-
cally for absorption employing the multi-scan method imple-
mented in CrysAlisPro. The structure was solved using
program SHELXS-97 (Sheldrick, 1990) and refined using the
full-matrix LS procedure with SHELXL-2014/7 (Sheldrick,
2008). We provide supplementary crystallographic informa-
tion containing crystal data and structure refinement results
for the compounds (Table S1). CIF files with further details
of the crystal structures reported in the paper have been depos-
ited with the Cambridge Crystallographic Data Centre
(CCDC), under deposition numbers CCDC 1550502, 882149,
882148, 1550503, for compound 1, 3, 9 and 18 respectively.
These data can be obtained free of charge from the CCDC
via www.ccdc.cam.ac.uk/data_request/cif.
2.3.1. X-ray single crystal structure for compound 1
C14 H10 Cl N O S, Mr = 275.74 g mol
1, crystal size = 0.60 
0.26  0.14 mm3, triclinic, space group P-1, a = 8.6648(5) A˚,
b = 10.5621(6) A˚, c = 14.3541(9) A˚, a= 76.201(5), b=
85.160(5), c= 84.746(5), V = 1267.74(14) A˚3, Z = 4. 5687
independent reflections were collected (from 10,246 total
reflections), 3792 with I > 2r(I), Rint: 0.0193. Anisotropic dis-
placement parameters were employed for non-hydrogen
atoms. All H atoms were located at the stereo-chemically
expected positions and they were refined using a riding model.
LS weights of the form w= 1/[r2(Fo
2) + (0.0489P)2] where P
= (Fo2 + 2Fc2)/3, were employed. R[F2 > 2r(F2)] = 0.0366,
wR(F2) = 0.0882.Please cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
for antifungal activityN-haloacetyl phenothiazines and derivatives –>. Arabian JourA bond lengths and angles table is provided as supplemen-
tary crystallographic information for the compound
(Table S2).
2.3.2. X-ray single crystal structure for compound 3
C15H12 Cl NO S2,Mr = 321.83 g mol
1, crystal size = 0.40 
0.30  0.15 mm3, triclinic, space group P-1, a = 9.8991(3) A˚, b
= 12.0627(5) A˚, c = 13.0691(4) A˚, a= 81.548(3), b= 72.306
(3), c= 82.987(3), V = 1465.65(8) A˚3, Z = 4. 6798 indepen-
dent reflections were collected (from 14,763 total reflections),
4069 with I > 2r(I), Rint: 0.0254. Anisotropic displacement
parameters were employed for non-hydrogen atoms. All H
atoms were located at the expected positions and they were
refined using a riding model. LS weights of the form w= 1/
[r2(Fo2) + (0.0557P)2] where P = (Fo2 + 2Fc2)/3, were
employed. R[F2>2r(F2)] = 0.0424, wR(F2) = 0.1001.
A bond lengths and angles table is provided as supplemen-
tary crystallographic information for the compound
(Table S3).
2.3.3. X-ray single crystal structure for compound 9
C16 H15 Cl N2 O3 S2, Mr = 382.87 g mol
1, crystal size =
0.25  0.22  0.16 mm3, monoclinic, space group P21/c, a =
8.9238(15) A˚, b = 14.987(3) A˚, c = 12.730(3) A˚, b= 89.883
(10), V = 1702.6(5) A˚3, Z = 4. 3338 independent reflections
were collected (from 5448 total reflections), 2102 with I > 2r
(I), Rint: 0.0454. Anisotropic displacement parameters were
employed for non-hydrogen atoms. All H atoms were located
at the expected positions and they were refined using a riding
model. LS weights of the form w= 1/[r2(Fo2) +
(0.1126P)2] where P = (Fo2 + 2Fc2)/3, were employed. R
[F2>2r(F2)] = 0.067, wR(F2) = 0.1728. The crystal structure
was refined as two component merohedric twin. The twin
law was defined by the matrix 1 0 0, 0 1 0, 0 0 1. The frac-
tional contribution for each twin domain was obtained from
refinement (0.47/0.53). A bond lengths and angles table is pro-
vided as supplementary crystallographic information for the
compound (Table S4).
2.3.4. X-ray single crystal structure for compound 18
C14 H14 N2 O2 S2, Mr = 306.39 g mol
1, crystal size = 0.35 
0.25  0.19 mm3, monoclinic, space group P21/n, a = 10.0358
(5) A˚, b = 11.3657(6) A˚, c = 13.0516(9) A˚, b= 101.758(6),
V = 1457.48(15) A˚3, Z = 4. 3248 independent reflections were
collected (from 5132 total reflections), 2068 with I > 2r(I),
Rint: 0.0342. Anisotropic displacement parameters were
employed for non-hydrogen atoms. All H atoms were located
at the expected positions and they were refined using a riding
model. LS weights of the form w= 1/[r2(Fo2) +
(0.0580P)2] where P = (Fo2 + 2Fc2)/3, were employed. R
[F2>2r(F2)] = 0.0424, wR(F2) = 0.1024.
A bond lengths and angles table is provided as supplemen-
tary crystallographic information for the compound
(Table S5).
2.4. Evaluation of the antifungal activity
The compounds 1–17 and conventional antifungal agents
against yeasts and filamentous fungi: amphotericina B
(AMB), 5-fluorocitosine (5-FC), fluconazole (FCZ), itracona-and derivatives: Preparation, characterization and structure-activity relationship
nal of Chemistry (2017), https://doi.org/10.1016/j.arabjc.2017.11.019
N-haloacetyl phenothiazines and derivatives 5zole (ITZ), voriconazole (VCZ) and terbinafine (TBF), were
evaluated following the CLSI guidelines (formerly NCCLS),
document M27A3 and M38A2 (Clinical and Laboratory Stan-
dards Institute reference method for broth dilution antifungal
susceptibility testing of filamentous fungi; approved standard,
2008, CLSI Document M38-A2; Wayne, PA and Clinical and
Laboratory Standards Institute, reference method for broth
dilution antifungal susceptibility testing of yeasts; approved
standard, 2008, CLSI Document M27-A3; Wayne, PA). The
assayed yeast were: a) Candida albicans (n = 40) and Candida
non-albicans (n = 26) that included: C. parapsilosis, C. glab-
rata, C. krusei, C. tropicalis and b) Cryptococcus neoformans
(n = 60). The filamentous fungi tested were: a) Aspergillus
(n = 25) that included: Aspergillus fumigatus, A. flavus, A.
niger, A. nidulans, A. terreus and b) Fusarium and Acremonium
species (n = 12). Briefly, fungi were grown onto Saboureaud
glucose agar during 2 days for yeasts and up to 7 days for
the filamentous fungi. The media used was RPMI-1640 buf-
fered with MOPS at pH 7. For each drug, stock solutions were
prepared in the appropriate solvent and the final concentra-
tions were ranged from 256 to 0.25 mg/mL for AMB, 5-FC,
FCZ, ITZ, VCZ, TBF and compound 1, and from 512 to
0.50 mg/mL for the remaining compounds. After, the stock
solutions were diluted in the media to be inoculated into 96-
well-flat-bottom micro titer plates. Final inoculums for yeasts
were 0.5–5  103 CFU/mL, and for filamentous fungi 0.5–5 
104 CFU/mL. After incubation at 30 C, spectrophotometer
and visual reading were determined in order to obtain the min-
imal inhibitory concentration (MIC) for each strain and drug
tested. The mathematical treatment of the values found for
the Gmean and MIC90, was carried out using Microsoft Office
Excel 2007 program.
2.5. QSAR study
The ground-state geometry of compounds 1–17 was optimized
within the Density Functional Theory (DFT) using the B3LYP
functional and 6-31G* basis set. The quantum calculations
included full optimization of the geometric structures and eval-
uations of the atomic charges according to the Merz-Kollman
scheme.
We use Gaussian, ChemAxon and HyperChem software in
order to obtain the different descriptors used to calculate the
potential QSAR models.
We analyzed uniparameter models in all the cases and bipa-
rameter models when the number of compounds was statisti-
cally enough to validate this model (n  5 for each
descriptor used). In all biparameter models, we checked the
orthogonality of the descriptors.
3. Results and discussion
3.1. Chemistry
A serie of N-acetyl phenothiazines (2–6) and one N-
acetylphenoxazine (7) were synthesized, in excellent yields and
very short reaction time, using microwave irradiation (MW)
(Table 1). The use of MW allowed reduce the reflux time and
use of friendly solvents, compared with that previously reported
in the literature (Bansode et al., 2009). Compounds 2 and 3were
obtained by treatment of 2-chlorophenothiazine (12) and2-Please cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
for antifungal activityN-haloacetyl phenothiazines and derivatives –>. Arabian Jourmethylthiophenothiazine (13), both commercially available,
with chloroacetyl chloride. Compounds 4, 5 and 6 were synthe-
sized from phenothiazine (14), also commercially available, and
bromoacetyl bromide, dichloroacetyl chloride and trifluo-
roacetic acid, respectively. Compound 7 was obtained by treat-
ment of phenoxazine with acetyl chloride.
Compounds 1, 8–11 (Table 1) and compounds N-
chloroacetylcarbazol (15), 2-chloro-N,N-diphenylacetamide
(16) and 2-chloro-N-[2-(phenylthio)phenyl]acetamide (17)
were obtained as it was previously described (Sarmiento
et al., 2011).
3.1.1. 1H NMR analysis
1H NMR spectra of N-chloroacetyl substituted phenothiazi-
nes, at room temperature, such as compounds 2, 3 and, 9
showed asymmetry in the molecules, which manifested itself
through the display of methylene hydrogen atoms as an AB
system with a geminal coupling constant between 10 and 14
Hz; in contrast to that observed in the 1H NMR spectrum of
compounds 1, 4–8 and 10 where these hydrogen atoms
appeared as a singlet. Furthermore, other authors described
the multiplicity of these hydrogen atoms, for example for com-
pound 2, as a singlet (Bansode et al., 2009). The correlation
spectrum (HMQC) of compounds 2 and 9 helped us to affirm
that both hydrogen atoms were joined to the same carbon
atom, which confirmed their diastereotopicity. The non-
equivalence of a pair of hydrogen atoms joined to a single car-
bon atom, in a molecule of such characteristics, indicates the
presence of asymmetry in it (Silverstein et al., 2005). The
acquisition of 1H NMR spectra in deuteron chloroform of
compound 2, when it was heating from 290 K to 322 K,
showed that both signals coalesce near 313.0 K (show in Sup-
plementary Material: Fig. S1). A similar experiment conducted
on compound 9 enabled the observation of the coalescence of
both doublets into one singlet at a temperature near 323.0 K.
When the temperature was lowered until 270 K in both com-
pounds, 2 and 9, could be observed that AB system corre-
sponding to the methylene group was conserved. Similar
results were observed for compound 3.
Considering the dynamic process involved in the conversion
of 2, 3 and 9 and based on the conducted 1H NMR experi-
ments, the energetic barriers (DGc
–) related to the interconver-
sion of compound 2 and 9 were calculated using Eq. (1):
DG–c ¼ 4:57103Tc logTc  log kcoal þ 10:32ð Þ
kcal
mol
ð1Þ
where:
Tc: coalescence temperature,
kcoal: coalescence constant.
Coalescence constant was calculated using the Eq. (2) that
takes into account the coupling constant of the exchangeable
hydrogen atoms (Jackman and Cotton, 1975).
kcoal ¼ 1
2
p
ﬃﬃﬃ
2
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
m1  m2ð Þ2 þ 6J2
h ir
ð2Þ
where:
J: coupling constant of the exchangeable hydrogen atoms,
m: frequency,
m and J: both values are measured at a lower temperature
than the Tc, where it is possible to determine the maximum
spacing between m1 and m2.and derivatives: Preparation, characterization and structure-activity relationship
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Table 1 Synthesis of phenothiazines 2–6, 9–11 and phenoxazines 7, 8.
Compound Z R R’ Reagent %
1 S COCH2Cl H Chloroacetyl chloride Sarmiento et al. (2011)
2 S COCH2Cl Cl Chloroacetyl chloride 90.0
3 S COCH2Cl SCH3 Chloroacetyl chloride 85.0
4 S COCH2Br H Bromoacetyl bromide 98.0
5 S COCHCl2 H Dichloroacetyl chloride 60.0
6 S COCF3 H Trifluoroacetic acid 70.0
7 O COCH3 H Acetyl chloride 90.0
8 O COCH2Cl H Chloroacetyl chloride Sarmiento et al. (2011)
9 S COCH2Cl SO2N(CH3)2 Chloroacetyl chloride Sarmiento et al. (2011)
10 S COCH3 H Acetyl chloride Sarmiento et al. (2011)
11 S CH2CH2Cl H 1+ B2H6 Sarmiento et al. (2011)
6 G.P. Sarmiento et al.For compound 2 the Dm was 37 Hz at 280.0 K and J was
13.06 Hz so the kcoal calculated was 108.66 s
1.
For compound 9 the Dm was 86 Hz at 280.0 K and J was
13.33 Hz so the kcoal calculated was 204.35 s
1.
Using the values of kcoal found, DGc
– calculated was:
For compound 2, where Tc is 313 K, DGc
–= 15.42
kcal/mol,
For compound 9, where Tc is 323 K, DGc
–= 15.53
kcal/mol.
3.1.2. 13C NMR analysis
13C NMR spectra of N-chloroacetyl substituted phenothiazi-
nes, recorded at room temperature, show coincidence of the
observed 13C NMR shift values (Table 2) for N-
acetylphenothiazine (10) and N-acetylphenoxazine (7)
(Sarmiento et al., 2011) with those reported in the literature
for these compounds (Ragg et al., 1983). The chemical shifts
are in agreement with the values presented in this work for
related structures: 1, 4–6, 8 and confirm a certain degree of
nitrogen-pyramidalization (sp3) of the atom of nitrogen of
the N-acylderivatives of the phenothiazines, even if they are
nitrogen atoms which simultaneously aniline-amide character-
istic. The displacement values at the carbon atoms, especially
those at the ortho and para positions at the N-10 atom, indicate
a clear deshielding effect, from the expected values for carbon
atoms in the presence of the electron donor effect (by reso-
nance) of a nitrogen atom. This fact can be attributed to the
folding of the molecules which leads to the pyramidalization
of the nitrogen atom and determines shift values in the13C
NMR spectrum close to those of an unsubstituted benzene
ring.
3.2. X-ray crystallographic analysis
In an initial approach, a non-common NMR spectrum may be
associated with the atropisomerism phenomenon. Then, thePlease cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
for antifungal activityN-haloacetyl phenothiazines and derivatives –>. Arabian Jourcrystallographic analysis allows the proper characterization
of the phenomena. Taking this into account, the single crystal
X-ray diffraction (SCXRD) studies were performed from those
compounds whose crystals were suitable. One molecule of
compound 1, in the asymmetric unit by SCXRD, shows a
‘‘butterfly like” folding of the tricycle system and the
extraposition of the substituent on the N-10, larger than a
hydrogen atom (Supplementary Material Fig. S2), as was
described by Malrieu and Pullman (1964).
Fig. 2 shows the molecule obtained by SCXRD in the
asymmetric unit of compound 9 (R = SO2N(CH3)2) and its
precursor 18, previously described (Sarmiento el al., 2011). It
is possible to observe that in compound 9, the substituent
group in the N-8 occupies the extra position, whereas in its
precursor 18, the hydrogen atom on the N-7 is in the endo
position.
In the same figure, the packing diagram in the unit cell for
compounds 9 and 18 are shown (bottom panel). In the unit cell
of compound 9, four molecules can be observed, two of which
are the enantiomeric forms of the other two. This confirms the
inherent chirality of the tricycle system asymmetrically
substituted.
As calculated, taking into account NMR dynamic experi-
ments, the energy barrier of interconversion between these
conformational enantiomers would be 15.53 kcal/mol. The cal-
culated energetic barrier would correspond to the ring move-
ment (‘‘ring flipping”) and the consequent conversion of one
enantiomer into another (Fig. 3) and would be the cause of
observed spectra.
According to the classification proposed by LaPlante,
(LaPlante et al., 2011) the energetic barrier calculated for com-
pounds 2 and 9 would position them as Class 1 of the confor-
mational isomers, which leads us to assert that their
development as an only active species is a correct approach.
It could be also obtained the crystallographic data for com-
pound 3 (R = SCH3), in whose crystals two type of conform-and derivatives: Preparation, characterization and structure-activity relationship
nal of Chemistry (2017), https://doi.org/10.1016/j.arabjc.2017.11.019
Table 2 13C NMR shift values (ppm) for N-acetylphenothiazine and N-acetylphenoxazine derivatives.
Compound number C1 (C9) C2 (C8) C3 (C7) C4 (C6) C11 (C14) C12 (C13) CO CH3 (CH2) (CH)
1 126.5 127.4 127.3 128.1 137.9 133.2 165.5 41.8
4 126.5 127.3 127.3 127.4 138.0 128.1 165.7 29.7
5 126.5 127.4 127.4 127.8 137.2 128.3 163.1 63.7
6 126.5 127.4 127.9 128.2 136.8 133.4 156.0 116.2
7 125.4 123.6 127.1 117.1 129.7 151.3 169.3 23.3
8 124.3 123.7 127.6 117.1 128.5 150.9 165.3 41.5
10 126.7 126.9 127.1 127.9 138.9 132.9 169.3 23.0
Fig. 2 Molecule of compounds 9 (left top panel) and 18 (right top panel) showing the numbering scheme used and displacement
ellipsoids drawn at the 50% probability level. Unit cell diagram in the crystal packing of compounds 9 (left bottom panel) and 18 (right
bottom panel).
N-haloacetyl phenothiazines and derivatives 7ers (forms A and B) were observed. They arise from the differ-
ent spatial orientation adopted by the substituent chain on the
nitrogen atom. A disorder manifests itself to level of thePlease cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
for antifungal activityN-haloacetyl phenothiazines and derivatives –>. Arabian Jourmethylthio group (such conformers are shown in Supplemen-
tary Material Fig. S3). The crystal of this compound also
shows the existence of both enantiomers for each of the twoand derivatives: Preparation, characterization and structure-activity relationship
nal of Chemistry (2017), https://doi.org/10.1016/j.arabjc.2017.11.019
8 G.P. Sarmiento et al.conformers, containing the unit cell four molecules, two corre-
sponding to the enantiomers of form A and two to the enan-
tiomers of form B.
3.3. Antifungal evaluation
In a previous study, the antifungal activity of PIP and PMZ, as
well as some synthetic precursors of them has been described
(Sarmiento et al., 2011). Given the fact that the length of the
carbon chain joined to the N-10 atom is very important in
the physiological activity of phenothiazine compounds
(antipsychotic vs. antihistaminic activities) and having into
account that N-chloroacetyl phenothiazine (1) was found to
be the most active one against different strains of yeast and fil-
amentous fungi, related compounds 2–11 and 15–17, have
been evaluated as antifungal agents against: Cryptococcus neo-
formans, Candida albicans, Candida non-albicans (C. glabrata,
C. krusei, C. parapsilosis, C. tropicalis), Aspergillus (A. fumiga-
tus, A. flavus, A. terreus, A. niger, A. nidulans) and
Acremonium-Fusarium. In this study three phenothiazine pre-
cursors (12–14), as well as six antifungal drugs clinically used
have been included: amphotericina B (AMB), 5-
fluorocitosine (5-FC), fluconazole (FCZ), itraconazole (ITZ),
voriconazole (VCZ) and terbinafine (TBF). The results
obtained (Gmean and MIC90) against different strains corre-
sponding to 163 (n = 163) clinical isolates are showed in
Table 3.
Among phenothiazine derivatives, compounds 1 and 4 were
active against all the strains tested. Compound 4 was much
more active against yeasts than filamentous fungi, and com-
pound 1 was more active against filamentous fungi than yeasts.
Compounds 15–17, which not conserved the phenothiazine
motif in their structure, but they are derivatives of N-a-
haloacylaniline, showed interesting activity against all the
strains assayed. For the other compounds different activities
were observed. Compounds 2 and 3 were much more active
against yeast than filamentous fungi. However, compound 3
was inactive against Candida non-albicans. Compound 8, a
phenoxazine compound, showed good activity against yeast
and filamentous fungi with the exception of Aspergillus species.
Compounds 5–7 and 9, 11 as well as 15 have poor activity or
are inactive against almost all strains, with the exception of
Cryptococcus neoformans. Compounds 10, 16 and 17 are prac-
tically inactive with all the strains assayed.Fig. 3 Equilibrium between c
Please cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
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For the QSAR study, 20 molecular descriptors were consid-
ered. They include electronic descriptors: HOMO, LUMO,
Dipole Moment, Hydration Energy, Polarizability; steric
descriptors: Surface Area, Volume, Molar Mass, Minimum
projection area (mPA), Maximum projection Area (MPA),
Minimum projection radius (mPR), Maximum projection
radius (MPR), Length perpendicular to minimum area, Length
perpendicular to maximum area, Topological polar surface
area, van der Waals Surface Area, Solvent accessible surface
area; lipophilic descriptors: logP, as well as some hybrid descrip-
tors: Molar Refractivity, logS. As biological descriptor, the
pGmean expressed in millimolar1 was used. In Table 4, the
pGmean values for each strain and the values of the descrip-
tors which resulted in a suitable correlation with the biological
descriptor are included.
In order to construct equations which relate the antifungal
activity with the descriptors, the lineal correlation coefficients
for each one were estimated. When the R2 was higher than
0.60, it was checked the possibility of biparameter equation,
according with the number of active compounds for each
strain and the orthogonality of the descriptors. A quadratic
correlation was also attempted when it enhanced the lineal cor-
relation previously obtained. Having into account the selective
activity of some compounds on particular strain, the calcula-
tion were carried out independently for each strain assayed
(see Table 4).
Analyzing the possible mathematical functions that explain
the activity on Aspergillus strains, for which 8 of the 17 com-
pounds tested were moderately active, no acceptable linear
relationship could be found with any descriptor tested. The
best of them, the MPR, resulted in an R2 of 0.45 with a stan-
dard deviation (sd) of 0.48, which although unacceptable,
allowed to estimate from the shape of the corresponding graph
(Fig. 4A), a quadratic relation, expressed by the Eq. (3).
pGmean ¼ 241:05 77:76MPRþ 6:28MPR2 ð3Þ
n ¼ 8 R2 ¼ 0:82 sd ¼ 0:20
When a similar analysis was performed on Acremoniun-
Fusarium strains where only 7 of the 17 compounds studied
showed activity, an acceptable linear relationship was found,
also with the MPR descriptor, resulting in an R2 of 0.82 withonformational enantiomers.
and derivatives: Preparation, characterization and structure-activity relationship
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Table 3 Antifungal activity of the compounds assayed. The concentrations are expressed in lg/mL.
Assayed compounds Aspergillusa Acremonium-Fusarium Cryptococcus neoformans Candida albicans Candida non albicansb
(n = 25)c (n = 12)c (n = 60)c (n = 40)c (n = 26)c
Gmeand/ Gmeand/ Gmeand/ Gmeand/ Gmeand/
MIC90
e MIC90
e MIC90
e MIC90
e MIC90
e
AMB 1.15/4.00 1.00/2.40 0.18/0.5 0.20/1.00 0.25/1.00
5-FC 66.50/256.00 211.90/256.00 7.60/32.00 0.10/0.925 0.11/1.50
FCZ 160.21/256.00 256.00/256.00 8.40/32.00 0.13/2.80 0.37/13.60
ITZ 0.06/0.25 11.27/32.00 0.02/0.06 0.01/0.25 0.04/0.25
VCZ 0.04/0.29 3.03/8.00 0.03/0.25 0.01/0.50 0.02/0.50
TBF 0.09/0.50 10.08/32.00 1.10/12.00 1.98/4.40 0.34/4.00
1 5.15/64.00 2.27/32.00 9.05/32.00 11.62/256.00 15.72/256.00
2 135.01/>512 i 1.80/4.00 3.86/32.00 25.40/32.00
3 77.71/>512 120.18/>512 2.67/32.0 2.50/16.00 i
4 3.78/12.80 3.31/4.00 0.83/4.00 1.22/4.00 2.38/6.00
5 i i 21.02/>512 84.03/>512 181.02/>512
6 i i 11.41/>512 i i
7 i i 13.22 /512 i i
8 i 3.76/>512 7.53/>512 3.39/>512 19.17/>512
9 i i 20.46/>512 i 92.18/614.40
10 i i 108.74/>512 i i
11 i i 20.49/>512 i i
12 39.95/>512 i 92.63/>512 i i
13 i i 103.75/>512 i i
14 i i 30.68/>512 172.28/>512 181.02/>512
15 58.59/>512 32.00/>512 12.39/>512 8.28/64.00 7.13/128.00
16 39.95/>512 9.07/64.00 14.47/64.00 54.03/>512 87.32/>512
17 98.71/>512 38.66/>512 7.71/>512 150.20/>512 113.46/>512
(a) Include: A. fumigatus, A. flavus, A. terreus, A. niger, A. nidulans. (b) Include: C. glabrata, C. krusei, C. parapsilosis, C. tropicalis. (c) Where n:
represents the number of isolates tested for the indicated strain; (d) Gmean is the resulting concentration of calculating the nth root of the
product of the CIM n determined experimentally; (e) MIC90 is the concentration that inhibits growth of 90% of the isolates tested for each case.
For example for 40 isolates of Candida albicans, the compound 1 need a concentration of 256 lg/mL to inhibit the growth of 36 isolates and i:
inactive at the concentrations tested.
Note: There were highlighted in bold the studied compounds’ Gmean values  32 lg/mL.
Table 4 Biological and molecular descriptors used in the best models found.
pGmeanc (mM1)
Assayed
compound
Aspergillusa Acremonium-
Fusarium
Cryptococcus
neoformans
Candida
albicans
Candida non-
albicansb
HOMO
(eV)
LUMO
(eV)
mPR
(A˚)
MPR
(A˚)
1 1.7287 2.0845 1.4839 1.3753 1.2441 8.4553 0.3974 5.06 5.72
2 0.3613 – 2.2364 1.9051 1.0868 8.5823 0.5327 4.99 6.31
3 0.6172 0.4278 2.0811 2.1097 – 8.5713 0.5466 5.19 6.5
4 1.9279 1.9856 2.5863 2.4191 2.1288 8.4477 0.3881 5.16 5.71
5 – – 1.1690 0.5672 0.2339 8.5243 0.4762 5.09 5.71
6 – – 1.4129 – – 8.5745 0.4470 4.81 5.68
7 – – 1.2314 – – 8.6471 0.1348 4.55 5.77
8 – 1.8393 1.5377 1.8843 1.1318 8.8304 0.3065 5.11 5.72
9 – – 1.2722 – 0.6184 8.7248 1.3572 5.06 7.13
10 – – 0.3462 – – 8.3028 0.2304 4.46 5.75
11 – – 1.1064 – – 7.8886 0.0470 4.72 5.79
12 0.7672 – 0.4019 – – 7.9747 0.3458 4.11 6.47
13 – – 0.3738 – – 7.9025 0.3936 4.11 6.87
14 – – 0.8126 0.0632 0.0417 7.8137 0.0976 4.18 5.9
15 0.6190 0.8817 1.2938 1.4688 1.5337 8.9684 0.5542 5.48 5.97
16 0.7889 1.4328 1.2300 0.6578 0.4493 9.0728 0.1004 4.57 5.77
17 0.4269 0.8340 1.5342 0.2446 0.3664 8.4212 0.0841 5.07 6.08
(a). Include: A. fumigatus, A. flavus, A. terreus, A. niger, A. nidulans. (b) Include: C. glabrata, C. krusei, C. parapsilosis, C. tropicalis. (c) Gmean is
the resulting concentration of calculating the nth root of the product of the CIM n determined experimentally, express in mM.
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10 G.P. Sarmiento et al.an sd of 0.30. This relationship could be optimized by studying
the quadratic relation with the same descriptor, in a similar
way of the Aspergillus behavior, resulting in the Eq. (4)
(Fig. 4A):
pGmean ¼ 162:41 51:15MPRþ 4:04MPR2 ð4Þ
n ¼ 7 R2 ¼ 0:95 sd ¼ 0:07
The MPR is the radius for the maximal projection area
(MPA) of the studied compound, which is read at a length per-
pendicular to maximum area (LpMA), from the center of mass
of the molecule. mPR is the radius for the minimum projection
area (mPA) of the studied compound, which is read at a length
perpendicular to minimum area (LpmA), from the center of
mass of the molecule (for a better comprehension see Supple-
mentary Material Fig. S4).
These results would indicate the dependence of the activity
observed for the genus Aspergillus, Acremonium-Fusarium of a
parameter of steric nature that would find an improvement in
its activity, in the absence of substituent on the tricycle system.
The mathematical function shed light a similar dependence of
the activity for both filamentous fungi (Fig. 4A).
A similar study was carried out for the strains of Candida
albicans and non-albicans, which were sensitive to 10 of the
17 compounds tested, in most cases with very near Gmean val-
ues to each other for the same compound assayed. The search
for linear relationships was not optimal, with none of the 21
descriptors. In both cases, the mPR and LUMO descriptors
showed an incipient linear correlation, although statistically
unacceptable. Both parameters were studied, both in a bipara-
metric relation, as in a quadratic relation, obtaining no
improvement with respect to the initial situation. Discarding
compound 5, which has low activity for both strains, was
achieved in both cases an important improvement, Eqs. (5)
and (6):
Candida albicans
pGmean ¼ 0:74 12:80 LUMO 14:92 LUMO2 ð5Þ
n ¼ 9 R2 ¼ 0:84 sd ¼ 0:38Fig. 4 Estimated QSAR models of: A. Eqs. (3) (blue line) and (
Please cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
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pGmean ¼ 0:07 4:79 LUMO 3:16 LUMO2 ð6Þ
n ¼ 9 R2 ¼ 0:69 sd ¼ 0:43
In the case of Eq. (6), the statistics values are border for the
cut-off values, so it was decided to analyzed a new selection,
discarding compound 9, in which the sulphonamide group lead
to a very different distribution of electronic density in the
molecule. Therefore, an optimization of the model could be
reached, Eq. (7) (Fig. 4B):
pGmean ¼ 0:53 9:78 LUMO 11:57 LUMO2 ð7Þ
n ¼ 9 R2 ¼ 0:76 sd ¼ 0:34
In Fig. 4B, it can be seen that the shape corresponding to
Eqs. (5) and (7) has the same pattern for all studied yeasts.
In this case, it could be concluded that for the genus Candida,
the dependence of the activity would be linked to an electronic
type factor, such as LUMO, finding the optimal value close to
0.4 eV.
When Cryptococcus neoformans strains were studied, hav-
ing into account that they were sensitive to all compounds
tested (Table 4) no linear, multiparametric, or quadratic
acceptable correlation was found with any of the descriptors,
or combinations thereof. So, it was decided to choose a set
of compounds that did not include that ones whose pGmean
was less than 0.5 (values with a Gmean > 90 lg/ml) –therefore
compounds 10, 12 and 13 were discarded - leaving a popula-
tion of 14 compounds. This selection also did not show accept-
able linear, multiparametric or quadratic correlation. Taking
into account the values of pGmean and comparing these with
the values obtained for the strains previously studied, it was
decided to separate two sets of compounds. One of them con-
sists of 6 inactive compounds or with a pGmean less than 0.5
(5, 6, 7, 9, 11 and 14), for all other strains studied. These ones
are only active on Cryptococcus neoformans strains. The best
mathematical relation obtained for this group was the quadra-
tic expression dependent on mPR, Eq. (8):4) (black line) and B. Eqs. (5) (blue line) and (7) (black line).
and derivatives: Preparation, characterization and structure-activity relationship
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N-haloacetyl phenothiazines and derivatives 11pGmean ¼ 22:72þ 9:90mPR 1:02mPR2 ð8Þ
n ¼ 6 R2 ¼ 0:76 sd ¼ 0:03
The other group of compounds, 1–4, 8 and 15–17, com-
prises 8 derivatives which are also active with most of the other
fungal genera studied, independently of the morphology of the
fungi strain assayed. In studying the mathematical function
between pGmean values and the 21 molecular descriptors,
no acceptable linear or quadratic correlation could be estab-
lished in any case.
4. Conclusion
In this work, it was developed a simple and successful method
of synthesis of N-acylphenotiazines and derivative compounds
using MW. The synthesized compounds were tested as antifun-
gal agents and the obtained results were compared with the
activity showed for six antifungal drugs clinically used:
AMB, 5-FC, FCZ, ITZ, VCZ and TBF. Compounds 4 and
8, resulting of the isosteric replacement in compound 1, select
as a lead compound, of the atom of chlorine by bromine in
compound 4 and sulphur by oxygen in compound 8 represent
an optimized structure for 4, and equivalent one for 8. A pos-
sible phenomena of atropisomerism, in mono-substituted phe-
nothiazines in one of their benzene ring, and observed through
the diastereotopic signals of the methylene protons, was stud-
ied using dynamic NMR. Through these experiments it was
possible to calculate an energetic barrier, near to16kcal/mol
at room temperature, for the conversion of the conformers.
Thus, it was possible to conclude that such compounds do
not exhibit atropisomerism, since atropisomers present rota-
tional barriers of above 20 kcal/mol at room temperature.
Surprisingly, compounds 1, 2 and 15 previously synthesized
by other authors, as precursors of more complex phenothiazi-
nes or diphenylamine N-acyl substituted, had not been tested
as antifungal agents (Bansode et al., 2009; Kumar and
Mishra, 2015).
As a first sight, a qualitative relationship between molecular
structure and biological activities (SAR) of the compounds
synthesized and evaluated, would conclude that:
– The presence of the residue chloroacetyl on the nitrogen
atom increases the activity. Precursors were less active or
inactive with respect to the corresponding N-chloroacetyl
derivatives for most of the strains tested.
– The replacement of the chlorine atom (compound 1) by the
bromine one (compound 4) led to the most active com-
pound in this series, being more active that some antifungal
agents currently in clinical use, such as 5-FC or FCZ.
– Introducing another chlorine atom in the chloroacetyl
group (5) or replacement of the chloromethyl group by tri-
fluoromethyl (6) leads to less active compounds than those
monohalogenated derivatives.
– The presence of phenothiazine system seems not to be
essential for the antifungal activity.
In order to shed light in the structural requirements for the
antifungal activity, a QSAR study was carried out. The antim-
icotic activity of the studied compounds over the strains with
filamentous morphology: Acremonium-Fusarium, Aspergillus
shows a quadratic dependence with MPR. It is higher asPlease cite this article in press as: Sarmiento, G.P. et al., N-haloacetyl phenothiazines
for antifungal activityN-haloacetyl phenothiazines and derivatives –>. Arabian JourMPR decrease, in the studied compounds. This descriptor is
involved with both MA and mA, so the activity is enhanced
in the absence of substituent in the aromatic rings, as well as
the presence of N-monohaloacetyl chain on the aniline nitro-
gen atom.
In the case of genus Candida, the activity is enhanced in the
case of electron acceptor molecules, with an optimal value of
LUMO near to 0.4 eV, as well as the presence of N-
monohaloacetyl chain on the aniline nitrogen atom. This last
requirement is the same as in the cases of Acremonium-
Fusarium, Aspergillus.
Finally, in the case of Cryptococcus neoformans, where all
the compounds tested resulted active, this activity seems to
be explain by different ways. For that compounds that are
active only on Cryptococcus neoformans, the dependence with
mPR with an optimal value of 4.85 A˚, would indicate that
the presence of a substituent on the aniline nitrogen atom,
enhanced the activity. However, for the more active derivatives
it could not be possible found an adequate mathematical cor-
relation. As Cryptococcus neoformans is an unconventional
dimorphic fungus that can grow either as yeast or in a filamen-
tous form (Zhai et al., 2013), and taking into account that we
worked with clinical isolations, the dependence of their activity
could be related with more than one molecular descriptor,
related with one of filamentous or yeast fungi.
All these results together, might lead to propose that the N-
haloacylaniline could be part of the pharmacophoric group,
which should be included in further structural optimization,
for the development of prototype molecules as potential anti-
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